Biomedical Technology Development and Dissemination (BTDD) Centers (RM1)

The Biomedical Technology Development and Dissemination (BTDD) program supports Centers for the late-stage development of cutting-edge technologies, with established feasibility, to prepare them for dissemination to the broader biomedical research community. Qualifying centers should be at the leading edge of their field in both technology development and engagement of the relevant research community. Like the Biomedical Technology Research Resource (BTRR) program, the BTDD program focuses on two goals: developing and disseminating enabling technologies and providing the research community access to those technologies, through three activities: Technology Development Projects (TDP), Driving Biomedical Projects (DBPs), and Community Engagement (CE).

This program, with an RM1 activity code, replaces the long-standing BTRR program. The current Funding Opportunity Announcement for the BTDD program is PAR-20-104: Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed). Potential applicants are strongly encouraged to contact NIGMS staff at least 10 weeks before the application due date to ascertain whether the proposed project is appropriate for an NIGMS BTDD Center.

Prospective applicants with technologies requiring significant technology development may consider applying for NIGMS Technology Development Program (R21 and R01). Prospective applicants with mature technologies may consider applying for the NIGMS National and Regional Resources (R24) or the NIGMS Mature Synchrotron Resources (P30).

Christina Liu, Ph.D. PE
Program Director
Division of Biophysics, Biomedical Technology, and Computational Biosciences
National Institute of General Medical Sciences
National Institutes of Health
45 Center Drive MSC 6200
Bethesda, MD 20892-6200

​​
​​